Clinical Trials Logo

ROS1-fusion Positive Tumor clinical trials

View clinical trials related to ROS1-fusion Positive Tumor.

Filter by:
  • None
  • Page 1

NCT ID: NCT03497624 Recruiting - Clinical trials for ROS1-fusion Positive Tumor

ALCMI-006: A Prospective Biospecimen Collection Study From Patients With ROS1-Fusion Positive Tumors

Start date: April 23, 2018
Phase:
Study type: Observational

Patient Derived Xenografts (PDXs) are models to study tumor growth, response to anti-cancer therapies, and resistance to anti-cancer therapies. The purpose of this study is to develop up to 24 PDX models for ROS1-fusion driven cancers to be used for research purposes only. That is, these patient derived PDX models will have no immediate benefit to the patient from whom the tumor specimen was obtained. Rather, these PDX models will be used to inform the study of ROS1-fusion driven cancers at large.